(1)
Göppner, D.; Müller, J.; Krüger, S.; Franke, I.; Gollnick, H.; Quist, S. R. High Incidence of Naevi-Associated BRAF Wild-Type Melanoma and Dysplastic Naevi under Treatment With the Class I BRAF Inhibitor Vemurafenib. Acta Derm Venereol 2014, 94, 517-520.